TMPO and Alzheimer disease: Long non-coding RNA (lncRNA)-TMPO-AS1, a downstream target of ALKBH5, affects AD progression partly by binding with EZH2 to epigenetically regulate interleukin-1 receptor-associated kinase 4 (IRAK4).